Post-earnings recap
Reported
Mon, Mar 7, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
TG Therapeutics reported a loss per share that was worse than expected, yet the stock rose by 9.75%. This increase may reflect investor optimism or a broader market trend, as specific details from the earnings call are not available to provide context.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.37 | N/A | -13.85% |
No transcript is on record, and the analysis is based solely on numerical results.